Irina Antonijevic
Director/Board Member at 4SC AG
Net worth: 97 699 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Bailey | M | 68 | 10 years | |
| Vladimir Coric | M | 53 | 9 years | |
| Julia Gregory | F | 71 | 7 years | |
| John Childs | M | 81 | 10 years | |
| Robert Hugin | M | 69 | 4 years | |
| George Clark | M | - | 5 years | |
| Michael Heffernan | M | 59 | 4 years | |
| Kimberly Gentile | F | 56 | 9 years | |
| Clemens M. Doppler | M | 64 |
Verinos Pharmaceuticals GmbH
| 19 years |
| Douglas G. Gray | M | - | - | |
| Kishan Mehta | M | 38 | 3 years | |
| Matthew Buten | M | 62 | 3 years | |
| Kathleen Masch-Wiest | F | - | 2 years | |
| Irfan Qureshi | M | - | - | |
| Gastón Ortega | M | - | 2 years | |
| Barbara Douglas | F | - |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Paloma Moraleda | F | - | 2 years | |
| Megan M. Dow | M | - | 4 years | |
| Michael Schlenk | M | - | 2 years | |
| Keith Flanagan | M | - |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Lisa Stocking | F | - | - | |
| Kathryn L. Biberstein | F | 65 |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | 4 years |
| Nick Kozauer | M | - | 1 years | |
| Jason Loveridge | M | 63 | 8 years | |
| Rachel McMinn | M | 51 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | 3 years |
| Manfred Rüdiger | M | 59 | 19 years | |
| Chris Barrett | M | - | - | |
| Stephen Webster | M | 63 |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | 4 years |
| Jennifer Porcelli | F | - | 2 years | |
| David Saunders | M | - | - | |
| Warren Volles | M | - | - | |
| Nessan Bermingham | M | 51 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | 2 years |
| Helmut Jeggle | M | 53 | 16 years | |
| Jon Blaskovich | M | - | - | |
| Tim Allsopp | M | - |
The University of Edinburgh
| 30 years |
| Bruce Car | M | 61 | 2 years | |
| Melissa Beiner | M | - | - | |
| Caroline Dircks | M | - | 4 years | |
| Hans Tanner | M | 72 | 7 years | |
| Susanne Danhauser-Riedl | M | - | 9 years | |
| Douglas Kerr | M | 57 |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | 5 years |
| Helga Rübsamen-Schaeff | M | 75 | 9 years | |
| Julian Baker | M | 57 |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | - |
| Clifford Bechtold | M | - | - | |
| Markus Guilherme Dieken | M | - | 5 years | |
| Horst Wildemann | M | 82 |
Technische Universität München
| 36 years |
| Maryellen McQuade | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henri A. Termeer | M | 78 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
| Ralph Lassig | M | - |
Technische Universität München
| 12 years |
| Elyse Stock | M | 66 | 5 years | |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Andreas Schaller | M | - |
Technische Universität München
| 6 years |
| William Sibold | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
| Elisabetta Castiglioni | M | 59 |
Technische Universität München
| 4 years |
| Anna Niedl | M | - | 2 years | |
| Gabriele Sommer | F | 60 |
Technische Universität München
| 6 years |
| Peter Heinold | M | - |
Technische Universität München
| 5 years |
| Frank Hermann | M | - | - | |
| Charles Conway | M | 62 | 5 years | |
| John Tilton | M | 56 | 6 years | |
| Josias Fantato De Pontes | M | 58 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Christian Kohlpaintner | M | 61 |
Technische Universität München
| 8 years |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Wolfgang Söhngen | M | - | 19 years | |
| Ilham Akbar Habibie | M | 61 |
Technische Universität München
| 8 years |
| Enno Spillner | M | 55 | 11 years | |
| Ulrich Dauer | M | 59 | 16 years | |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Stefan Weingartner | M | 63 |
Technische Universität München
| 4 years |
| Daniel Vitt | M | 55 | 19 years | |
| Alvin Loh | M | - |
The University of Edinburgh
| 4 years |
| Raimund Klinkner | M | 59 |
Technische Universität München
| 6 years |
| Werner J. Bauer | M | 73 |
Technische Universität München
| 5 years |
| Anton Mindl | M | 67 |
Technische Universität München
| 3 years |
| Gareth John Rudd | M | - |
The University of Edinburgh
| 1 years |
| Bassam Samir Shehadah Al-Talhouni | M | 60 |
The University of Edinburgh
| 3 years |
| Ricardo Malta | M | 56 |
Technische Universität München
| 4 years |
| Marc Hundsdorf | M | 56 |
Technische Universität München
| 5 years |
| Markus H. Thoma | M | 66 |
Technische Universität München
| 3 years |
| Markus Herbert Koebler | M | - |
Technische Universität München
| 6 years |
| Tarek Kamel | M | 62 |
Technische Universität München
| 3 years |
| Mark Lazarowicz | M | 70 |
The University of Edinburgh
| 3 years |
| Georg Lingg | M | 60 |
Technische Universität München
| 6 years |
| Georg Koch | M | 61 |
Technische Universität München
| 5 years |
| Juan Ignacio Conrat Niemerg | M | - |
Technische Universität München
| 4 years |
| Erhardt Barth | M | - |
Technische Universität München
| 3 years |
| Werner Lang | M | 56 |
Technische Universität München
| 4 years |
| Jörg Dieter Ulrich | M | - |
Technische Universität München
| 4 years |
| Herbert Diess | M | 65 |
Technische Universität München
| 3 years |
| Bernhard Müllinger | M | - |
Technische Universität München
| 4 years |
| Volker Kefer | M | 68 |
Technische Universität München
| 3 years |
| Min Wan Ip | M | - |
The University of Edinburgh
| 4 years |
| Roland M. Dürre | M | - |
Technische Universität München
| - |
| Klaus Hollmeier | M | 61 |
Technische Universität München
| 4 years |
| George Crawford | M | - |
The University of Edinburgh
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 49 | 49.00% |
| Germany | 44 | 44.00% |
| United Kingdom | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Irina Antonijevic
- Personal Network
